Skip to content
MarketScale
‹ Back to Industries

Sciences

WHY 2018 IS THE YEAR TO GET YOUR DIGESTIVE TRACT BACK ON TRACK

You may be surprised to learn that your body is jam packed with trillions of bacteria. But don’t worry, most of these bacteria in your body are located in your gut, and they are actually doing good work for you! This little ecosystem, referred to as the gut microbiome, is constantly working to improve your digestion, enhance…

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Sciences · Promoted Content
Share
WHY 2018 IS THE YEAR TO GET YOUR DIGESTIVE TRACT BACK ON TRACK

Key takeaways

01

You may be surprised to learn that your body is jam packed with trillions of bacteria.

02

But don’t worry, most of these bacteria in your body are located in your gut, and they are actually doing good work for you!

03

This little ecosystem, referred to as the gut microbiome, is constantly working to improve your digestion, enhance…

You may be surprised to learn that your body is jam packed with trillions of bacteria. But don’t worry, most of these bacteria in your body are located in your gut, and they are actually doing good work for you! This little ecosystem, referred to as the gut microbiome, is constantly working to improve your digestion, enhance your immune system, and protect you from harmful bacteria, all three of which are great reasons to focus on improving your gut health this year. The impact of gut health on overall well-being has been a very newsworthy topic in recent years. If you’ve been following the research and developments up until now, but haven’t taken the next step, then 2018 should be your year to do so, and here’s why.

The positive impact of a healthy gut has been proven time and time again. The gut microbiome contains thousands of different kinds of microbes, and is unique to each person. Strains of both good and bad bacteria exist in a delicate balance that effects your whole body. Not enough good bacteria, and functions such as digestion begin to degrade, leading to poor nutrient absorption, gas and bloating, even mental fogginess and weight fluctuations. With more good bacteria, functions such as digestion obviously improve, along with other functions that occur outside your gut, such as your ability to burn and store fat.

A healthy gut is not achieved from its bacterial make-up alone. Enzymes work with the gut microbiome to break down food into absorbable nutrients. If the body experiences a digestive enzyme deficiency, a healthy diet can go to waste as nutrients are not broken down and put to use in the body.

One of the most universally recommended methods to improve your gut health is through the use of enzymes and probiotics, good bacteria, either in foods or supplements. Without a healthy gut, a healthy diet can only go so far.

The long-term effects of a healthy gut can impact every part of your life. The GI tract is almost like a second brain, affecting moods, energy levels, libido, creative output, etc. Gastrointestinal health is extremely important to your overall well-being, which is why enzymes and probiotics are essential to restoring your intestines to a more optimal state. This can be achieved through both enzyme-rich raw foods and supplements.

But simply purchasing any supplement won’t solve your problems. When buying supplements, it is important to look at what they contain, and how much of it. When it comes to probiotics, be sure to check the specific strains and the Colony Forming Unit (CFU) number, which indicates the number of viable bacterial cells in each serving, to make sure that the supplement you choose is powerful enough to impact the flora in your gut. For enzymes, be aware that the potency of these ingredients isn’t measured in milligrams as you may be accustomed to seeing, but instead in varying Activity Units. A supplement facts panel that lists its enzymes measured by weight (in milligrams) may not have a high enough activity to make the difference you’re seeking.

Whether your preferred delivery method is foods or supplements, improving your gut health should be resolution #1 for a healthier 2018.

Deerland Enzymes & Probiotics is a leading specialty formulator and contract manufacturer of enzyme- and probiotic-based dietary supplements. With a team of industry experts working in a state-of-the-art lab, we’re positioned to serve customers from the initial stages of product conceptualization, through the design phase, and on to final formulation and contract manufacturing.

Read more at deerlandenzymes.com

About the author

S
Sciences

New to MarketScale?

MarketScale is the platform Sciences companies use to turn their own experts into content like this. Want the short overview?

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Sciences Insights

Quotient Sciences launches Phase I study of what it calls the first AI-formulated drug in the clinic

Quotient Sciences launches Phase I study of what it calls the first AI-formulated drug in the clinic

Quotient Sciences has initiated a Phase I clinical study at its UK facility for an oral solid dose formulation designed using artificial intelligence — what the company believes is the first AI-formulated drug to reach human clinical evaluation. The study, cleared by the UK's Medicines and Healthcare products Regulatory Agency, will assess safety and pharmacokinetics in healthy volunteers. The program, which used Intrepid Labs' machine learning algorithm, signals a broader shift in how contract drug development organizations are integrating AI across formulation and clinical workflows.

  • 01Quotient Sciences initiated a Phase I study of an AI-designed oral solid dose formulation at its UK facility following MHRA approval — the first such case the company believes has been reported.
  • 02The formulation was developed using Intrepid Labs' advanced machine learning algorithm in combination with Quotient Sciences' Translational Pharmaceutics platform.
  • 03The milestone is part of a broader CRDMO strategy to embed AI-enabled approaches across formulation development and clinical workflows, with implications for the wider contract pharma sector.

Jun 17, 2026

Quotient Sciences launches Phase I trial of what it calls the first AI-formulated drug to reach the clinic

Quotient Sciences launches Phase I trial of what it calls the first AI-formulated drug to reach the clinic

Quotient Sciences has initiated a Phase I clinical study of an oral solid dose formulation designed using AI, cleared by the UK's MHRA and conducted at the company's UK facility. The trial—built on machine learning algorithms from partner Intrepid Labs and Quotient's Translational Pharmaceutics platform—aims to validate AI as a direct contributor to formulation design rather than just an upstream analytical tool. Benchling characterizes the broader moment as biotech entering a "builder phase," in which leading organizations embed AI capability at the bench level rather than running isolated pilots.

  • 01Quotient Sciences has dosed healthy volunteers in a Phase I study it describes as the first clinical evaluation of an AI-designed oral formulation, following approval from the UK's MHRA.
  • 02The formulation was developed using advanced machine learning algorithms from Intrepid Labs, integrated with Quotient Sciences' Translational Pharmaceutics platform.
  • 03Benchling identifies a sector-wide shift toward embedding AI capability directly at the bench, moving beyond isolated pilots to structural adoption across biotech R&D.

Jun 17, 2026

Tekniplex Showcases Sustainable Materials Innovation at Paris Packaging Week 2026

Tekniplex Showcases Sustainable Materials Innovation at Paris Packaging Week 2026

At Paris Packaging Week 2026, Tekniplex showcased its latest sustainable materials innovations, emphasizing the intersection of materials science and brand storytelling. The company's booth featured a living wall and digital displays to engage a sustainability-conscious audience, highlighting advanced materials for sustainability and product performance in cosmetics packaging.

  • 01Tekniplex emphasized sustainable materials innovation at Paris Packaging Week 2026.
  • 02The company's booth featured eco-friendly design elements and immersive digital displays.
  • 03Tekniplex highlighted advancements in recyclable sealing systems and materials for cosmetics.

Apr 9, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

S
Sciences